AlzeCure publishes its interim report for January - September 2026
STOCKHOLM, SE / ACCESS Newswire / November 11, 2026 / AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6) today announced that its interim report for the period January - September 2026 is now available on the company's website: …
Weiterlesen »